Table 3.
Baseline demographic and clinical variables of participants in study 2
| UC | ET | P Value | |
|---|---|---|---|
| n | 21 | 19 | |
| Age, yr | 54.7 ± 14.1 | 51.5 ± 11.8 | 0.441 |
| Sex (F/M) | 10/11 | 8/11 | 0.726 |
| BMI, kg/m2 | 28.3 ± 5.8 | 28.3 ± 6.2 | 0.965 |
| eGFR, ml·min−1·1.73 m−2 | 42.2 ± 14.9 | 40.2 ± 15.2 | 0.665 |
| Systolic blood pressure, mmHg | 123 ± 16 | 129 ± 17 | 0.259 |
| Diastolic blood pressure, mmHg | 79 ± 11 | 81 ± 13 | 0.740 |
| V̇o2peak, ml·kg−1·min−1 | 24.4 ± 6.6 | 26.4 ± 5.4 | 0.287 |
| Medication, no. (%) | |||
| ACE-I | 8 (38) | 12 (63) | 0.102 |
| ARB | 9 (43) | 4 (21) | 0.129 |
| Statin | 10 (48) | 12 (63) | 0.252 |
Values are means ± SD or no. (%); n, no. of subjects. UC, usual care; ET, exercise training.